Kroon, J., Kooijman, S., Cho, N
The hormones and biomarkers tested include: Estradiol Progesterone Luteinizing hormone (LH) Follicle-stimulating hormone (FSH) Dehydroepiandrosterone (DHEA) Cortisol Thyroid-stimulating hormone (TSH) Free T3 and T4 Thyroid peroxidase antibodies (TPO) Free testosterone This test requires blood and saliva samples, which you should provide at different times of your menstrual cycle
They can order a blood test to check your levels and recommend the appropriate treatment
When Combination Might Be Considered: In select cases, clinicians might discuss combination therapy for patients who: Have achieved partial but insufficient response to maximally tolerated tirzepatide Have specific dietary patterns with high fat intake Have previously responded well to orlistat but need additional intervention Understand and accept the increased side effect burden For patients with BMI 40 kg/m or 35 kg/m with obesity-related comorbidities, referral for bariatric surgery evaluation should be considered per American Society for Metabolic and Bariatric Surgery guidelines, rather than pursuing multiple pharmacotherapies
In addition, postmenopausal women not on hormone therapy had improvements in fasting glucose ( P = .001), HbA1c ( P = .0002) and systolic BP ( P = .008) from baseline to 12 months
